Cite

HARVARD Citation

    Pitrez, P. et al. (2017). Impact of omalizumab in children from a middle‐income country with severe therapy‐resistant asthma: A real‐life study. Pediatric pulmonology. 52 (11), pp. 1408-1413. [Online]. 
  
Back to record